AvaxNews

Biotech Stocks Break Down, a Bad Omen – Barron’s

stocks - Google News Mar 27th, 2014 Stocks.



Biotech Stocks Break Down, a Bad Omen
Barron's
Several component stocks dove multiple percentage points and a few, such as Biogen Idec (BIIB), were off more than 8%. That is a serious change of mood. The biotech ETF fell sharply below its key 50-day moving average, suggesting a change in trend.

Comments are closed

Поговорим о Кино

Copyright Financial News Focus | White Kitchen | Tax Haven Countries